| Name | Title | Contact Details |
|---|
FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered `undruggable`.
Genitope Corporation is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Economist Intelligence Unit is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Keros Therapeutics is dedicated to the discovery and development of novel therapeutics for neuromuscular diseases
Aldeyra Therapeutics, Inc., is a biotechnology company focused primarily on the development of products to treat diseases thought to be related to endogenous free aldehydes, a naturally occurring class of toxic molecules. The company has developed NS2, a product candidate designed to trap free aldehydes. Aldeyra plans to begin clinical testing of NS2 in 2014 for the treatment of Sjögren-Larsson Syndrome and acute anterior uveitis. NS2 has not been approved for sale in the U.S. or elsewhere.